Unusual volume stocks in Monday's session
AtaiBeckley Inc ATAI
$7.18
▲ +0.00%
(+$0.00)
⬇️ Below Yest. Low
🗓️ Earnings Next Week
Open
$7.19
Prev Close
$7.18
Day Range
$7.18 – $7.21
52W Range
$3.27 – $7.22
Market Cap
$2.66B
Beta
1.59
EPS (TTM)
$-2.23
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-18 |
| Shares Out. | 369,950,000 |
| Website | ataibeckley.com/ ↗ |
| Phone | 13026587581 |
| Employees | 99 |
About AtaiBeckley Inc
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
AtaiBeckley Inc is a publicly traded company under the ticker symbol ATAI on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
21 analysts (2026-07-01)